Barclays
RNXT icon

Barclays’s RenovoRx RNXT Stock Holding History

Barclays’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13K Buy
+1,151
New +$1.05K ﹤0.01% 4919
2025
Q4 		– Sell
-118
Closed -$150 – 5608
2025
Q3 		$150 Buy
+118
New +$140 ﹤0.01% 5256
2025
Q2 		– Sell
-43
Closed -$43 – 5493
2025
Q1 		$43 Buy
+43
New +$50 ﹤0.01% 5151

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Barclays's RNXT Position: Q2 2026 in Review

Barclays opened a new position in RenovoRx (RNXT) in Q2 2026: 1,151 shares worth $1.13K. The stake represents ﹤0.01% of the portfolio and ranks #4919 among its holdings. This is a return to the name: Barclays previously reported a position in RNXT as recently as Q3 2025.

Barclays first reported a position in RNXT in Q1 2025 and has held it in 3 quarters since. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • Barclays held 1,151 shares of RenovoRx worth $1.13K as of Q2 2026.
  • RenovoRx was a new Barclays position in Q2 2026.
  • RenovoRx made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4919 holding.
  • Barclays first reported a position in RenovoRx in Q1 2025 and has held it in 3 quarters since.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.